The trademark ENLIVEN was filed by Ganeden Biotech, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 30, 2011, and received one opposition filed on September 29, 2011 by Abbott Laboratories on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion, (c) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by BAKER & MCKENZIE LLP and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 29, 2011
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
The renewal of the trademark was recorded by the office on March 7, 2022.
of the trademark registration was recorded on March 7, 2022. Relative errors of the trademark registration was recorded on January 31, 2013. Appointment and Replacement of representative of the trademark registration was recorded on December 10, 2017. Appointment and Replacement of representative of the trademark registration was recorded on January 6, 2021. Appointment and Replacement of representative of the trademark registration was recorded on April 5, 2021.